The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Types of Multiple Myeloma | International Myeloma Foundation
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
PDF) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients - Experimental Hematology
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Establishment of Five Human Myeloma Cell Lines
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Myeloma Explained | Haematology | Oncology | onthewards
Heterogeneity and Plasticity of Multiple Myeloma | IntechOpen
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
2-Methoxyestradiol at low dose induces differentiation of myeloma cells
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals
plus dead) labeled
NCI-H929细胞ATCC CRL-9068细胞H929人骨髓瘤细胞株购买价格、培养基、培养条件、细胞图片、特征等基本信息_生物风
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
